HomeStock ScreenerAbbott

Abbott Current Share Price | Abbott Stock Screener

ABBOTINDIA Pharmaceuticals
Live Share Price NSE
₹27270.00
▲ 1360.00 (5.25%)
2026-09-18 00:00:00
Live Share Price BSE
₹27273.30
▲ 1363.20 (5.26%)
2026-09-18 00:00:00
As of September 18, 2026, the live Abbott share price (NSE: ABBOTINDIA) is ₹27,270.00 on NSE and ₹27,273.30 on BSE, up 5.25% from the previous close, with shares trading between ₹26,035.00 and ₹27,490.00 in today's trading session, and a 52-week range of ₹25,180.00–₹30,250.00. Browse Abbott financial data to support your investment research. Use the Abbott stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Abbott Market Cap ₹55,513.80 Cr.
ABBOTINDIA P/E Ratio (TTM) 34.41
Abbott P/B Ratio 11.64
EPS (TTM) ₹730.36
Dividend Yield 2.51%
Debt to Equity 0.04
ABBOTINDIA 52 Week High ₹30250.00
Abbott 52 Week Low ₹25180.00
Operating Margin 28.00%
Profit Margin 22.14%
ABBOTINDIA Revenue (TTM) ₹7,295.00
EBITDA ₹2,260.00
Net Income ₹1,615.00
Total Assets ₹6,502.00
Total Equity ₹4,774.00

Abbott Current Share Price Chart

Track the current Abbott share price and stock price with an interactive chart. Analyse ABBOTINDIA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Abbott stock quote in one place.

Abbott Company Profile - Fundamental Screener

Screen Abbott company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ABBOTINDIA shares.
Abbott India Ltd is a leading multinational pharmaceutical company in India. It operates an owned manufacturing facility in Goa and works with various independent contract manufacturers across the country. The company sells its products primarily within India through independent distributors. Abbott India provides pharmaceutical products and solutions across various therapeutic...more
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
Chairperson/CEO Munir Shaikh
ISIN INE358A01014

Abbott Balance Sheet Screener

Screen ABBOTINDIA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 6,502 5,917 5,194 4,556 4,224 3,840 3,547 2,941 2,416 2,066
Current Assets 3,771 4,763 3,246 3,025 3,853 3,487 3,205 2,761 2,266 1,893
Fixed Assets 331 336 225 237 271 251 270 105 81 110
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 251 277 152 161 201 207 224 75 55 47
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 4,774 4,233 3,699 3,189 2,820 2,602 2,432 2,009 1,693 1,387
Share Capital 21 21 21 21 21 21 21 21 21 21
Reserves & Surplus 4,753 4,212 3,678 3,167 2,799 2,581 2,411 1,987 1,672 1,366

Abbott Income Statement Screener - Profit & Revenue Analysis

Screen Abbott income statement and profit fundamentals. Analyze ABBOTINDIA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Abbott share price evaluation.
Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 7,295 7,217 6,685 6,097 5,503 4,997 4,391 4,208 3,792 3,416 2,960 2,665 2,337
Expenses 5,036 5,037 4,715 4,396 4,143 3,832 3,389 3,337 3,074 2,774 2,505 2,250 1,977
EBITDA 2,260 2,180 1,970 1,701 1,360 1,165 1,002 871 718 642 455 415 360
Operating Profit % 28.00% 27.00% 26.00% 25.00% 23.00% 22.00% 21.00% 18.00% 16.00% 16.00% 14.00% 14.00% 13.00%
Depreciation 76 76 72 71 70 66 58 60 17 16 16 14 15
Interest 25 25 11 12 16 19 18 9 2 4 2 3 1
Profit Before Tax 2,158 2,079 1,887 1,618 1,274 1,080 926 803 699 622 437 398 344
Tax 557 527 473 417 324 281 235 210 249 220 160 143 115
Net Profit 1,615 1,552 1,414 1,201 949 799 691 593 450 401 277 255 229
EPS 759.80 730.36 665.62 565.28 446.80 375.87 325.04 279.04 211.93 188.81 130.19 120.12 107.75

Abbott Cash Flow Screener - Liquidity Fundamentals

Screen ABBOTINDIA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March
Operating Activities 1,319 1,012 1,213 893 948 727 626 499 153 307
Investing Activities -371 182 -416 -148 -396 -72 -401 -257 -215 -155
Financing Activities -1,066 -925 -745 -639 -637 -582 -217 -143 -102 -90
Net Cash Flow -118 269 52 107 -86 73 8 99 -165 62

Abbott Shareholding Pattern Screener

See Abbott shareholding pattern with promoter, FII, and DII holdings. Check Abbott promoter holding and ownership changes for ABBOTINDIA on TickJournal.
Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun
Promoter Holding 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
FII Holding 0.26% 0.38% 0.16% 0.16% 0.16% 0.18% 0.18% 0.18%
DII Holding 8.93% 8.78% 8.92% 9.19% 9.11% 9.00% 8.91% 8.81%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 13.38% 13.41% 13.66% 13.35% 13.43% 13.42% 13.80% 13.86%
Other Holding 2.43% 2.44% 2.28% 2.31% 2.31% 2.42% 2.12% 2.16%
Shareholder Count 75,866 78,320 69,934 67,584 71,199 75,801 69,382 71,588

Abbott Share Dividend Screener - Share Yield Analysis

Check Abbott dividend history with payout and yield data. View Abbott dividend details including ex-dates and amounts for ABBOTINDIA stock.
Period Dividend Per Share Dividend Yield
2026-March ₹656.00 2.51%
2025-March ₹475.00 1.83%
2024-March ₹410.00 1.33%
2023-March ₹325.00 1.20%
2022-March ₹275.00 1.26%
2021-March ₹275.00 1.55%
2020-March ₹250.00 1.67%
2019-March ₹65.00 0.42%
2018-March ₹55.00 0.75%
2017-March ₹40.00 0.73%

Abbott Stock Index Membership

See which indices include Abbott stock. Check ABBOTINDIA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX BSELVI
BSE INDEX BSEQUI
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MIDCAP
BSE INDEX MSL400
NIFTY 500
NIFTY HEALTHCARE
NIFTY LARGEMID250
NIFTY M150 QLTY50
NIFTY MIDCAP 150
NIFTY MIDSMALL INDIA CONSUMPTION
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MNC
NIFTY PHARMA
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP

Abbott Market Events Screener - Corporate Actions

Get Abbott corporate actions including splits, bonuses, and buybacks. Check Abbott stock events that may affect ABBOTINDIA share price.
Announcement Date Record Date Event Type Information Price Impact
2026-08-13 2026-08-13 Annual General Meeting NA 5.57%
2026-08-12 2026-08-12 Quarterly Result Announcement NA 0.45%
2026-07-24 2026-07-24 Dividend ₹ 131.00 /share 7.78%
2026-07-24 2026-07-24 Dividend ₹ 525.00 /share 7.78%
2026-05-11 2026-05-11 Quarterly Result Announcement NA 4.62%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 0.09%
2025-11-06 2025-11-06 Quarterly Result Announcement NA -1.36%
2025-08-13 2025-08-13 Annual General Meeting NA 6.57%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -1.83%
2025-07-25 2025-07-25 Dividend ₹ 475.00 /share 13.94%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 0.67%
2025-02-05 2025-02-05 Quarterly Result Announcement NA -1.42%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 2.06%
2024-08-08 2024-08-08 Annual General Meeting NA 8.45%
2024-07-19 2024-07-19 Dividend ₹ 410.00 /share 10.98%

Abbott Competitors Screener - Peer Comparison

Screen ABBOTINDIA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 444,717 36.34 61,674 12.69% 11,565 38.94
Divis Laboratories 243,116 83.41 11,067 13.95% 2,568 57.81
Torrent Pharmaceuticals 183,052 85.57 13,886 20.34% 2,138 42.03
Zydus Life Science 111,440 23.87 27,658 17.64% 5,026 43.86
Cipla 109,705 32.76 29,045 2.24% 3,870 35.04
Laurus Labs 102,870 95.29 6,868 22.01% 890 56.63
Dr Reddys Laboratories 95,152 30.15 35,059 3.90% 4,158 39.81
Aurobindo Pharma 94,535 25.82 34,145 5.56% 3,503 49.75
Lupin 93,504 16.93 29,039 26.75% 5,356 22.87
Mankind Pharma 92,759 45.72 14,636 14.85% 1,938 34.16

Abbott Company Announcements - News Screener

Screen ABBOTINDIA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-09-10 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-08-14 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-12 Unaudited Financial Results For The Quarter Ended June 30 2026. -
2026-08-12 Board Meeting Outcome for Outcome Of Board Meeting -
2026-08-04 Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026. -
2026-08-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-20 Communication Providing The Weblink Including Path Of Annual Report. -
2026-07-20 Business Responsibility and Sustainability Reporting (BRSR) -
2026-07-20 Annual General Meeting On August 13 2026. -
2026-07-20 Reg. 34 (1) Annual Report. -
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-26 Closure of Trading Window -
2026-06-17 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-06-15 Communication To Shareholders - Intimation About Tax Deduction At Source On Dividend -
2026-06-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-25 Announcement under Regulation 30 (LODR)-Change in Management -